These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 993625)

  • 1. Pharmacokinetics of amikacin in patients with normal or impaired renal function: radioenzymatic acetylation assay.
    Plantier J; Forrey AW; O'Neill MA; Blair AD; Christopher TG; Cutler RE
    J Infect Dis; 1976 Nov; 134 SUPPL():S323-30. PubMed ID: 993625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of amikacin in patients with impaired renal function.
    McHenry MC; Wagner JG; Hall PM; Vidt DG; Gavan TL
    J Infect Dis; 1976 Nov; 134 SUPPL():S343-8. PubMed ID: 993627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of amikacin in patients with renal insufficiency: relation of half-life and creatinine clearance.
    Pijck J; Hallynck T; Soep H; Baert L; Daneels R; Boelaert J
    J Infect Dis; 1976 Nov; 134 SUPPL():S331-41. PubMed ID: 993626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of amikacin and kanamycin.
    Kirby WM; Clarke JT; Libke RD; Regamey C
    J Infect Dis; 1976 Nov; 134 SUPPL():S312-5. PubMed ID: 993624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of type of dialyzer on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):197-202. PubMed ID: 6862725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of amikacin in subjects with normal renal function, in chronic renal failure and during hemodialysis].
    Oksenhendler G; Leroy A; Fillastre JP; Humbert G
    Nouv Presse Med; 1979 Oct; 8(42):3426-9. PubMed ID: 537888
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of peritoneal dialysis of the pharmacokinetics of amikacin.
    Matzke GR; Salem N; Bockbrader H; Blevins R
    Proc Clin Dial Transplant Forum; 1980; 10():302-4. PubMed ID: 7346850
    [No Abstract]   [Full Text] [Related]  

  • 9. Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure.
    Blair DC; Duggan DO; Schroeder ET
    Antimicrob Agents Chemother; 1982 Sep; 22(3):376-9. PubMed ID: 7137981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of amikacin in children with normal and impaired renal function.
    Lanao JM; Dominguez-Gil AA; Dominguez-Gil A; Málaga S; Crespo M; Santos F
    Kidney Int; 1981 Jul; 20(1):115-21. PubMed ID: 7300106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.
    Pechere JC; Dugal R; Pechere MM
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):49-56. PubMed ID: 467467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis.
    Regeur L; Colding H; Jensen H; Kampmann JP
    Antimicrob Agents Chemother; 1977 Feb; 11(2):214-8. PubMed ID: 848923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved acetylating radioenzymatic assay of amikacin, tobramycin, and sisomicin in serum.
    Stevens P; Young LS; Hewitt WL
    Antimicrob Agents Chemother; 1975 Mar; 7(3):374-6. PubMed ID: 1137391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):357-60. PubMed ID: 489203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.
    Bauer LA; Blouin RA
    Eur J Clin Pharmacol; 1983; 24(5):639-42. PubMed ID: 6873143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of amikacin overdose.
    Green FJ; Lavelle KJ; Aronoff GR; Vander Zanden J; Brier GL
    Am J Kidney Dis; 1981 Sep; 1(2):110-2. PubMed ID: 7332003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of renal failure and dialysis on the serum concentration of the aminoglycoside amikacin.
    Madhavan T; Yaremchuk K; Levin N; Pohlod D; Burch K; Fisher E; Cox F; Quinn EL
    Antimicrob Agents Chemother; 1976 Sep; 10(3):464-6. PubMed ID: 984789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of serum creatinine concentration and amikacin half-life.
    Levy J; Klastensky J
    J Clin Pharmacol; 1975 Oct; 15(10):705-7. PubMed ID: 1102570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of amikacin half-life during therapy in patients with renal insufficiency.
    Blaser J; Rüttimann S; Bhend H; Lüthy R
    Antimicrob Agents Chemother; 1983 Jun; 23(6):888-91. PubMed ID: 6614893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of the new aminoglycoside antibiotics: tobramycin, lividomycin, amikacin, sisomicin in the patient with normal renal function and in renal insufficiency. Dosage rules].
    Oksenhendler G; Leroy A; Humbert G; Fillastre JP; Winckler C
    Anesth Analg (Paris); 1977; 34(1):93-110. PubMed ID: 587022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.